血清C4与FGF19检测排除肠易激综合征腹泻型及功能性腹泻中胆汁酸腹泻的诊断性能特征
前瞻性研究101例肠易激综合征腹泻型(IBS-D)患者,空腹血清C4与FGF19呈负相关(Rs=-.342,P=.0005),基于C4升高诊断胆汁酸腹泻10例、基于FGF19降低诊断21例;与48小时粪便胆汁酸相比,C4和FGF19的特异性分别为83%和78%,提示两者可作为排除胆汁酸腹泻的筛查试验。
要点
- 101例IBS-D患者中,血清C4与FGF19呈负相关(Rs=-.342,P=.0005)。
- 与48小时粪便胆汁酸相比,C4特异性83%、FGF19特异性78%。
- 重复检测中C4的78%、FGF19的70%测量结果保持一致。
核心结论
- 在101例IBS-D患者中,空腹FGF19和C4水平具有良好的特异性和阴性预测值,提示可作为排除胆汁酸腹泻的筛查试验。
研究设计与样本
- 前瞻性研究空腹血清C4和FGF19在101例IBS-D患者中的表现。
主要发现
- 101例患者中血清C4与FGF19呈负相关(Rs=-.342,P=.0005)。
- 基于血清C4升高诊断胆汁酸腹泻10例(均值23.5±23.1 ng/mL)。
- 基于FGF19降低诊断胆汁酸腹泻21例(121.6±84.2 pg/mL)。
- 重复检测中C4的78%、FGF19的70%测量结果保持一致,在101例患者中分别有3%和11%持续阳性。
- 与48小时粪便胆汁酸相比,C4和FGF19的特异性分别为83%和78%。
关键数值与推荐
- 正常参考值:C4 ≥52.5 ng/mL(n=184),FGF-19 ≤61.7 pg/mL(n=50)。
- 与48小时粪便胆汁酸相比,C4特异性83%,FGF19特异性78%。
临床怎么用
- 原文结论提示空腹FGF19和C4可作为排除胆汁酸腹泻的筛查试验。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The serum biomarkers, elevated 7αC4 (C4) and decreased FGF19, have been proposed as screening tests for bile acid diarrhoea. AIM: To analyse prevalence, specificity and reproducibility of fasting C4 and FGF19 in identifying bile acid diarrhoea in patients with irritable bowel syndrome with predominant diarrhoea or functional diarrhoea (summarised as IBS-D). METHODS: We prospectively studied fasting serum C4 and FGF19 in 101 IBS-D patients; we reviewed data from 37 of the 101 patients with prior fasting serum C4 and FGF19 and from 30 of the 101 patients with prior faecal bile acids per 48 hours. We compared results with normal values (C4 ≥52.5 ng/mL [n=184], FGF-19 ≤61.7 pg/mL [n=50]). We used Spearman correlation and Bland-Altman plots to appraise reproducibility. RESULTS: Among the 101 patients, there was a negative correlation between serum C4 and FGF19 (Rs=-.342, P=.0005). Bile acid diarrhoea was diagnosed in 10 patients based on elevated serum C4 levels (mean 23.5±23.1 [SD] ng/mL) and 21 patients based on decreased FGF19 levels (121.6±84.2 pg/mL). With replicate tests in patients with stable IBS-D, 78% of C4 and 70% of FGF19 measurements remained concordant, with 3% and 11% respectively consistently positive for bile acid diarrhoea in the 101 patients. Compared to 48 hours faecal bile acids, specificity for C4 and FGF19 was 83% and 78%, respectively. Bland-Altman plots demonstrated greater reliability of C4 than FGF19. CONCLUSIONS: Among 101 patents with IBS-D, fasting FGF19 and C4 levels had good specificity and negative predictive value, suggesting utility as screening tests to exclude bile acid diarrhoea.
引用
- Vijayvargiya P, Camilleri M, Carlson P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther. 2017. PMID: 28691284. doi:10.1111/apt.14214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。